Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis

Table 1 Pre-operative demographics and baseline characteristics of the study population

	mean ± SD/ n (%)
Age in years (mean ± SD)	59.23 ± 6.52
HCV-related liver disease, n (%)	105 (87.5)
Hypertensive, n (%)	34 (28.3)
Diabetic, n (%)	36 (30)
Previous abdominal operations, n (%)	34 (28.3)
Child-Pugh class, n (%)
A5	90 (75)
A6	30 (25)
MELD score (mean ± SD)	8.54 ± 1.78
MELD score, n (%)
< 10	90 (75)
10-20	30 (25)
BCLC stage, n (%)
0	12 (10)
A	72 (60)
B	36 (30)
Pre-operative upper endoscopy
Oesophageal Varices, n (%)
No	78 (65)
Yes	42 (35)
Pre-operative imaging
Diameter of largest tumor in cm (mean ± SD)	4.57 ± 2.03
Tumor diameter > 5 cm, n (%)
No	86 (71.7)
Yes	34 (28.3)
Serum Bilirubin (mg/dL)	0.87 ± 0.34
Aspartate Aminotransferase (U/L)	53.2 ± 29.6
Alanine Aminotransferase (U/L)	44.32 ± 25.65
Serum Albumin (g/dL)	3.78 ± 0.48
International normalized ratio	1.16 ± 0.1
Serum creatinine (mg/dL)	0.86 ± 0.22
Platelets count ( 103/mm3)	141 ± 64.32
Serum AFP (ng/mL)	193.37 ± 343.37
Serum AFP (ng/mL), n (%)
< 20	52 (43.3)
20-400	30 (25)
> 400	20 (16.7)
Undocumented	18 (15)
Platelets < 150.000/mm3, n (%)	64 (53.3)
Anatomical resection, n (%)	22 (18.3)
Use of Harmonic scalpel, n (%)	40 (33.3)
Use of Habib sealer, n (%)	40 (33.3)
Use of CUSA, n (%)	2 (1.7)
Intraoperative bleeding, n (%)	4 (3.3)
Blood transfusion, n (%)	12 (10)
Plasma transfusion, n (%)	6 (5)
Grade of differentiation, n (%)
1 or 2	58 (48.3)
3 or 4	38 (31.7)
Undocumented	24 (20)
Lymph/vascular invasion, n (%)	44 (36.7)

HCV: Hepatitis C virus; MELD: Model for end-stage liver disease; BCLC: Barcelona clinic liver cancer; AFP: Alpha-fetoprotein; CUSA: Cavitron Ultrasonic Surgical Aspirator.